| Name | Title | Contact Details |
|---|
Mattson Jack Group is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Louis, MO. To find more information about Mattson Jack Group, please visit www.mattsonjack.com
Medifast, Inc. is a leading provider of clinically proven, doctor-recommended weight-loss and live healthy solutions. The companys product portfolio includes Medifast 5 & 1 Plan, OPTAVIA Coach-led Optimal Weight 5 & 1 Plan, Thrive by Medifast, and mor...
Nationally-renowned drug & alcohol addiction treatment provider delivering compassionate care through detox, residential/outpatient & virtual programs.
WELL™ Health is upending the $3.5 trillion healthcare market by helping patients and administrators break free of antiquated communication practices. This 2021 Best in KLAS for Patient Outreach software provides medical organizations with a single command center that connects the many tools they use, transforming everyday interactions between patients and the doctor`s front office.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.